Compare Alcon AG (ALC) vs ClearPoint Neuro Inc (CLPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs ClearPoint Neuro Inc — how do they compare? Alcon AG trades at $72.96 (market cap $36.44B), while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: Alcon AG is far larger — about 80.2× ClearPoint Neuro Inc's market cap, and Alcon AG pays a 0.48% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| ALC | CLPT | |
|---|---|---|
Market Cap | $36.44B | $454.21M |
Sector | Health | Health |
52-Week High | $90.12 | $29.60 |
52-Week Low | $62.02 | $8.66 |
Enterprise Value | $40.28B | $488.79M |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →
